Most Read Articles
Stephen Padilla, 19 Jul 2019
A quadruple combination antiretroviral therapy (cART) demonstrates similar effects when compared to a triple cART in treatment-naïve people with HIV, according to the results of a systematic review and meta-analysis.
Jairia Dela Cruz, 01 Jun 2020
Current three-drug combination antiretroviral therapy (ART) regimens have proven to be highly effective, and the use of the relatively inexpensive rilpivirine (RPV) appears to have considerably better tolerability profile than efavirenz or protease inhibitors in regimens containing abacavir plus lamivudine (ABC/3TC) for treatment-naïve patients, offering a good, less costly approach to suppressing HIV, as shown in a Singapore study.
05 Jun 2020
Darunavir lacks potent in vitro antiviral activity against SARS-CoV-2 and is therefore not supported for use in the treatment of COVID-19, according to a recent study.
Audrey Abella, 05 May 2020
Use of the investigational drug fostemsavir, a prodrug of the first-in-class HIV-1 attachment inhibitor temsavir, led to a significant reduction in the HIV-1 RNA* level of adults with multidrug-resistant HIV-1 infection with limited antiretroviral therapy (ART) options, according to the results of the ongoing phase III BRIGHTE** trial.

Arthritis (Patient Counselling Guide)

05 Jun 2020
Arthritis is a chronic disorder of the joints characterized by pain and inflammation. As a result, there is often a limitation or loss of movement of the part affected. Arthritis may take on many forms and the most common are osteoarthritis, rheumatoid arthritis and gouty arthritis. However, there are general symptoms that are common to all of these forms: swelling, warmth, redness and pain. If the common symptoms are observed for more than two weeks, it is highly possible that a patient is suffering from arthritis. In these conditions, it is best to see a healthcare professional specializing in the field, ie, an orthopedist or a rheumatologist.

* Click below to view Patient Counselling Guide in Thai
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 19 Jul 2019
A quadruple combination antiretroviral therapy (cART) demonstrates similar effects when compared to a triple cART in treatment-naïve people with HIV, according to the results of a systematic review and meta-analysis.
Jairia Dela Cruz, 01 Jun 2020
Current three-drug combination antiretroviral therapy (ART) regimens have proven to be highly effective, and the use of the relatively inexpensive rilpivirine (RPV) appears to have considerably better tolerability profile than efavirenz or protease inhibitors in regimens containing abacavir plus lamivudine (ABC/3TC) for treatment-naïve patients, offering a good, less costly approach to suppressing HIV, as shown in a Singapore study.
05 Jun 2020
Darunavir lacks potent in vitro antiviral activity against SARS-CoV-2 and is therefore not supported for use in the treatment of COVID-19, according to a recent study.
Audrey Abella, 05 May 2020
Use of the investigational drug fostemsavir, a prodrug of the first-in-class HIV-1 attachment inhibitor temsavir, led to a significant reduction in the HIV-1 RNA* level of adults with multidrug-resistant HIV-1 infection with limited antiretroviral therapy (ART) options, according to the results of the ongoing phase III BRIGHTE** trial.